| case report | Q2782326 |
| scholarly article | Q13442814 |
| P2093 | author name string | Min Jeong Kim | |
| Dae-Hong Jeon | |||
| Dong Jun Park | |||
| Se-Ho Chang | |||
| Hyun Seop Cho | |||
| Eun Jin Bae | |||
| Yire Kim | |||
| P2860 | cites work | Esomeprazole-induced rhabdomyolysis in a patient with heart failure | Q43129942 |
| Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial | Q43560922 | ||
| The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety | Q43650344 | ||
| Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole | Q43742706 | ||
| Rhabdomyolysis associated with omeprazole | Q44759072 | ||
| Proton pump inhibitor-induced rhabdomyolysis and hyponatremic delirium | Q46645894 | ||
| Pharmacokinetics of esomeprazole following varying intravenous administration rates | Q46858378 | ||
| Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19. | Q47683144 | ||
| Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. | Q52067661 | ||
| Autoimmune syndrome induced by omeprazole | Q72688921 | ||
| Rhabdomyolysis | Q81382814 | ||
| Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction | Q33148996 | ||
| Safety and efficacy of long term esomeprazole therapy in patients with healed erosive oesophagitis | Q33423526 | ||
| Rhabdomyolysis: a review | Q33957693 | ||
| Rhabdomyolysis and acute kidney injury | Q34018365 | ||
| Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. | Q34082482 | ||
| Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole | Q34320782 | ||
| Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole | Q34340193 | ||
| Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? | Q34535535 | ||
| Pharmacokinetic drug interaction profiles of proton pump inhibitors | Q34570478 | ||
| The other medical causes of rhabdomyolysis | Q35200530 | ||
| Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcers | Q36808048 | ||
| Proton pump inhibitors: an update of their clinical use and pharmacokinetics | Q37235086 | ||
| Omeprazole-associated rhabdomyolysis | Q43032100 | ||
| P433 | issue | 29 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | esomeprazole | Q553223 |
| rhabdomyolysis | Q917069 | ||
| P304 | page(s) | e4313 | |
| P577 | publication date | 2016-07-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | Rhabdomyolysis associated with single-dose intravenous esomeprazole administration: A case report | |
| P478 | volume | 95 |
| Q88458866 | Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database |
| Q47427297 | Translational High-Dimensional Drug Interaction Discovery and Validation Using Health Record Databases and Pharmacokinetics Models |
Search more.